NCT Number: NCT02203045
Outcomes Following Tourniquet and Non-Tourniquet Assisted Total Knee Arthroplasty
The overall goal of this study is to determine the effects of intraoperative tourniquet use during total knee arthroplasty (TKA), compared to TKA without the use of a tourniquet (NOTQT), for strength and functional recovery following simultaneous bilateral TKA. During the procedure, each patient will receive tourniquet-assisted TKA (TQT) on one lower extremity while the contralateral lower extremity undergoes TKA without the use of a tourniquet (NOTQT), except for briefly during component cementation. Tourniquets are commonly used in TKA to improve visualization of the surgical field and limit blood loss. However, studies suggest that tourniquet use may be associated with higher rates of medical complications and poor functional outcomes, including increased swelling, decreased muscle strength and altered neuromuscular activity. We will measure strength, voluntary muscle activation, and other functional outcomes for each lower extremity at 4 time points (preop; inpatient (24-72 hrs after surgery); 3 weeks; and 3 months following TKA). We hypothesize that lower extremities in the NOTQT group will demonstrate improved strength and performance when compared to lower extremities in the TQT group.
Looking for future studies?
Notify MeKey information
Age range
Up to 75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Univeristy of Colorado, Aurora, Colorado, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- undergoing primary, simultaneous bilateral knee arthroplasty for osteoarthritis
Exclusion criteria
- no neurological, vascular or cardiac problems that limit function or any unstable orthopaedic conditions that limit functional performance
Treatment and study plan
Primary outcomes
-
Change from baseline in Quadriceps Muscle Force
Time frame: Pre-operative, 3 weeks and 3 months post-operative
NOTQT will result in greater quadriceps muscle strength (primary outcome) after TKA, compared to TQT group. Benefits will be apparent at 48-72 hrs and 3 weeks (primary endpoint), and persist though 3 months following TKA
Secondary outcomes
-
Change from Baseline in Balance testing
Time frame: Pre-operatively, 3 weeks and 3 months post-operative
Patients will be asked to perform a test of unilateral balance ability. Patients will place both hands on their hips before assuming a single limb stance. Patients will attempt to hold this position for a maximum time of 60 seconds, although timing will stop if patients ever place both feet on the ground, if the non-stance leg braces against the stance leg to control balance, or if hands are removed from the hips to regain balance.
-
Change from Baseline in Isometric Hamstring Strength
Time frame: Pre-operatively, 3 weeks and 3 months post-operative
-
Change from Baseline from Voluntary Quadriceps Activation
Time frame: Pre-operative, 3 weeks and 3 months post-operative
-
Change from Baseline in Range of Motion
Time frame: Pre-operatively, 3 weeks and 3 months post-operatively
Knee flexion and extension range of motion (ROM) will be quantified using a standard long-arm goniometer with the patient lying in supine. Knee flexion ROM will be defined as the angle of maximal active bending of the knee. Knee extension ROM will be the angle of maximal straightening while the patient's heel is propped on a 10cm wooden block. If hyperextension is achieved, then the degrees of extension beyond zero will be recorded as a negative value.
Other outcomes
-
Radiographic Examination
Time frame: 1 to 2 months post surgery
Radiographic examination will be used to provide preliminary data on rates of fracture and tibiofemoral joint malalignment specific to the use of tourniquet during surgery.
-
Deep Vein Thrombosis Formation
Time frame: 48- 72 hours post operative
-
Postoperative blood loss
Time frame: 48 hours post surgery
-
Lower extremity edema
Time frame: 48- 72 hours postoperative
-
Verbal analog scale pain assessment
Time frame: Pre-Operative, 3 weeks and 3 months post-operative
Sponsors and collaborators
Lead sponsor
University of Colorado, Denver
Other
Collaborators
- Colorado Joint Replacement
- CommonSpirit Health
Registry information
Important dates
- Study start
- 2012
- Primary completion
- 2014
- First posted
- Jul 29, 2014
- Registry last updated
- May 15, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Verifying the Effectiveness of the NUsurface® System
NCT02108496
Arthritis, Joint Diseases
Indianapolis, Indiana, United States
View Trial DetailsComparison of Medial Knee Pain Between Patients With and Without Preoperative Tibia Vara Underging Mobile-bearing Unicompartmental Knee Arthroplasty
NCT07720024
Arthritis, Blount disease
Pathum Thani, Changwat Pathum Thani, Thailand
View Trial DetailsMedico-economic Interest of the Patient Matched Cutting Blocks (Ancillary) MyKnee ® LBS During the Poses of Complete Prosthesis of Knee GMK ®. Multicentric, Prospective, Controlled, Opened, Randomised Study About a Medical Device. (My Knee)
NCT01818401
Arthritis, Joint Diseases
Nantes, France
View Trial DetailsEffectiveness of Joint Distraction Versus Passive End Range Overpressure in Osteoarthritis:
NCT07710404
Arthritis, Joint Diseases
Faisalābad, Punjab Province, Pakistan
View Trial Details